Back
Rocket Pharmaceuticals Stock Price Chart
Sell
45
RCKT
Rocket Pharmaceuticals
Last Price:
22.47
Seasonality Move:
18.21%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is relatively stagnant and RCKT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.95 | Buy |
| 20-day SMA: | 21.92 | Buy |
| 50-day SMA: | 22.66 | Sell |
| 200-day SMA: | 24.09 | Sell |
| 8-day EMA: | 21.81 | Buy |
| 20-day EMA: | 22.09 | Buy |
| 50-day EMA: | 22.98 | Sell |
| 200-day EMA: | 23.61 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 51.59 | Buy |
| Chaikin Money Flow: | 1158313 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.27 - 22.89) | Buy |
| Bollinger Bands (100): | (22.34 - 28.24) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 22.48 while RCKT 8-day simple moving average is 21.95, which is a Buy signal.
- The stock price of RCKT is 22.48 while Rocket Pharmaceuticals 20-day SMA is 21.92, which makes it a Buy.
- Rocket Pharmaceuticals 50-day simple moving average is 22.66 while RCKT share price is 22.48, making it a Sell technically.
- RCKT stock price is 22.48 and Rocket Pharmaceuticals 200-day simple moving average is 24.09, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
45
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a Sell
The current Rocket Pharmaceuticals [RCKT] share price is $22.48. The Score for RCKT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
2.04B
Price in USD:
22.48
Share Volume:
1.39M
Rocket Pharmaceuticals 52-Week Range
52-Week High:
32.53
52-Week Low:
14.89
Sell
45
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?
The Rocket Pharmaceuticals stock price is 22.48 USD today. -
Will RCKT stock go up or go down?
Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rocket Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 22.48 while RCKT 8-day exponential moving average is 21.81, which is a Buy signal.
- The stock price of RCKT is 22.48 while Rocket Pharmaceuticals 20-day EMA is 22.09, which makes it a Buy.
- Rocket Pharmaceuticals 50-day exponential moving average is 22.98 while RCKT share price is 22.48, making it a Sell technically.
- RCKT stock price is 22.48 and Rocket Pharmaceuticals 200-day simple moving average is 23.61, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.11 per share, an increase this year of $0.37 per share, and an increase next year of $0.57 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
- RCKT Moving Average Covergence Divergence (MACD) indicator is -0.32, suggesting Rocket Pharmaceuticals is a Sell
- Rocket Pharmaceuticals Relative Strength Index (RSI) is 51.59, which suggest Rocket Pharmaceuticals is overbought
- The Bollinger Bands (25) for Rocket Pharmaceuticals is (21.27 - 22.89), which suggest Rocket Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Rocket Pharmaceuticals is (22.34 - 28.24), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.